British AI biotech spin-off of DeepMind
Google has reorganised its AI leadership: Demis Hassabis has stepped back from day-to-day running of DeepMind to become its chair and Alphabet chief scientist, and Koray Kavukcuoglu has been promoted to senior vice-president to run Google DeepMind. Several senior engineers, including Jeff Dean and Sanjay Ghemawat, have left to launch a new startup; Alphabet shares have fallen.
Arm Holdings chief executive Rene Haas says AI could one day help cure cancer, but the path is constrained by chip shortages and a demand surge for AI data centres. Multiple outlets report Haas’s remarks, framing a broaderAI-driven push in healthcare and manufacturing, while flagging supply constraints and broader market excitement.
Anthropic has built a wet lab in the San Francisco Bay Area to accelerate biology work, confirming a shift from in silico research to real-lab experimentation. The move comes amid warnings about AI risks and a looming IPO, with leadership stressing safety while pursuing faster drug development.